METHYLPHENIDATE HYDROCHLORIDE- methylphenidate hydrochloride tablet, extended release
Lannett Company, Inc.
----------
Dispense with Medication Guide available at: www.lannett.com/med-guide/methylphenidate-er-tabs-ab
MEDICATION GUIDE
Methylphenidate Hydrochloride (meth'' il fen' i date hye'' droe klor' ide) Extended-Release Tablets CII
Read the Medication Guide that comes with methylphenidate hydrochloride extended-release tablets before you or your child starts taking it and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking to your doctor about your or your child’s treatment with methylphenidate hydrochloride extended-release tablets.
What is the most important information I should know about methylphenidate hydrochloride extended-release tablets?
The following have been reported with use of methylphenidate HCl and other stimulant medicines:
1. Heart-related problems:
Tell your doctor if you or your child has any heart problems, heart defects, high blood pressure, or a family history of these problems.
Your doctor should check you or your child carefully for heart problems before starting methylphenidate hydrochloride extended-release tablets.
Your doctor should check your or your child's blood pressure and heart rate regularly during treatment with methylphenidate hydrochloride extended-release tablets.
Call your doctor right away if you or your child has any signs of heart problems such as chest pain, shortness of breath, or fainting while taking methylphenidate hydrochloride extended-release tablets.
2. Mental (Psychiatric) problems:
All Patients
Children and Teenagers
Tell your doctor about any mental problems you or your child have, or about a family history of suicide, bipolar illness, or depression.
Call your doctor right away if you or your child has any new or worsening mental symptoms or problems while taking methylphenidate hydrochloride extended-release tablets, especially seeing or hearing things that are not real, believing things that are not real, or are suspicious.
3. Painful and prolonged erections (priapism)
Painful and prolonged erections (priapism) have occurred with methylphenidate. If you or your child develop priapism, seek medical help right away. Because of the potential for lasting damage, priapism should be evaluated by a doctor immediately.
4. Circulation problems in fingers and toes [Peripheral vasculopathy, including Raynaud's Phenomenon]:
Tell your doctor if you have or your child has numbness, pain, skin color change, or sensitivity to temperature in your fingers or toes.
Call your doctor right away if you have or your child has any signs of unexplained wounds appearing on fingers or toes while taking methylphenidate hydrochloride extended-release tablets.
What are methylphenidate hydrochloride extended-release tablets?
Methylphenidate hydrochloride extended-release tablet is a central nervous system stimulant prescription medicine. It is used for the treatment of attention deficit and hyperactivity disorder (ADHD). Methylphenidate hydrochloride extended-release tablets may help increase attention and decrease impulsiveness and hyperactivity in patients with ADHD.
Methylphenidate hydrochloride extended-release tablets should be used as a part of a total treatment program for ADHD that may include counseling or other therapies.
Methylphenidate hydrochloride extended-release tablet is a federally controlled substance (CII) because it can be abused or lead to dependence. Keep methylphenidate hydrochloride extended-release tablets in a safe place to prevent misuse and abuse. Selling or giving away methylphenidate hydrochloride extended-release tablets may harm others, and is against the law.
Tell your doctor if you or your child has (or has a family history of) ever abused or been dependent on alcohol, prescription medicines, or street drugs.
Who should not take methylphenidate hydrochloride extended-release tablets?
Methylphenidate hydrochloride extended-release tablets should not be taken if you or your child:
Methylphenidate hydrochloride extended-release tablets should not be used in children less than 6 years old because it has not been studied in this age group.
Methylphenidate hydrochloride extended-release tablets may not be right for you or your child. Before starting methylphenidate hydrochloride extended-release tablets, tell your or your child's doctor about all health conditions (or a family history of) including:
Tell your doctor if you or your child is pregnant, planning to become pregnant, or breastfeeding.
Can methylphenidate hydrochloride extended-release tablets be taken with other medicines?
Tell your doctor about all of the medicines that you or your child takes including prescription and nonprescription medicines, vitamins, and herbal supplements. Methylphenidate hydrochloride extended-release tablets and some medicines may interact with each other and cause serious side effects. Sometimes the doses of other medicines will need to be adjusted while taking methylphenidate hydrochloride extended-release tablets.
Your doctor will decide whether methylphenidate hydrochloride extended-release tablets can be taken with other medicines.
Especially tell your doctor if you or your child takes:
Know the medicines that you or your child takes. Keep a list of your medicines with you to show your doctor and pharmacist.
Do not start any new medicine while taking methylphenidate hydrochloride extended-release tablets without talking to your doctor first.
How should methylphenidate hydrochloride extended-release tablets be taken?
What are possible side effects of methylphenidate hydrochloride extended-release tablets?
See "What is the most important information I should know about methylphenidate hydrochloride extended-release tablets?" for information on reported heart and mental problems.
Other serious side effects include:
Common side effects include: | |
|
|
Stimulants may impair the ability of you or your child to operate potentially hazardous machinery or vehicles. You or your child should exercise caution until you or your child is reasonably certain that methylphenidate hydrochloride extended-release tablets do not adversely affect your or your child's ability to engage in such activities.
Talk to your doctor if you or your child has side effects that are bothersome or do not go away.
This is not a complete list of possible side effects. Ask your doctor or pharmacist for more information.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
You may also report side effects to Lannett Company, Inc. at 1-844-834-0530.
How should I store methylphenidate hydrochloride extended-release tablets?
General information about methylphenidate hydrochloride extended-release tablets
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use methylphenidate hydrochloride extended-release tablets for a condition for which it was not prescribed. Do not give methylphenidate hydrochloride extended-release tablets to other people, even if they have the same condition. It may harm them and it is against the law.
This Medication Guide summarizes the most important information about methylphenidate hydrochloride extended-release tablets. If you would like more information, talk with your doctor. You can ask your doctor or pharmacist for information about methylphenidate hydrochloride extended-release tablets that was written for healthcare professionals. For more information about methylphenidate hydrochloride extended-release tablets call 1-844-834-0530.
What are the ingredients in methylphenidate hydrochloride extended-release tablets?
Active Ingredient: methylphenidate HCl
Inactive Ingredients: colloidal silicon dioxide, ethylcellulose, ferrosoferric oxide (18 mg, 27 mg, 54 mg), hypromellose, iron oxide yellow (18 mg, 27 mg), lactose monohydrate, magnesium stearate, microcrystalline cellulose, methacrylic acid and methyl methacrylate copolymer, polyethylene glycol, polysorbate (36 mg), talc, triethyl citrate, titanium dioxide, and red iron oxide (54 mg).
The extended-release tablets are printed with opacode® black ink containing ammonium hydroxide, ferrosoferric oxide, propylene glycol and shellac glaze.
This Medication Guide has been approved by the U.S. Food and Drug Administration.
Distributed by:
Lannett Company, Inc.
Philadelphia, PA 19136
CIB71985C
Rev. 07/2021